IMMX Earnings Immix Biopharma, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–16 of 16
| Q1 2026 | 2026-03-31 | -0.18 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -0.89 | 2026-03-25 | 10-K |
| Q3 2025 | 2025-09-30 | -0.61 | 2025-11-07 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.37 | 2025-08-08 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.15 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -0.76 | 2026-03-25 | 10-K |
| Q3 2025 | 2024-09-30 | -0.60 | 2025-11-07 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.36 | 2025-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.22 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -0.89 | 2025-03-25 | 10-K |
| Q3 2024 | 2023-09-30 | -0.65 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.42 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.18 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -0.59 | 2024-03-29 | 10-K |
| Q3 2023 | 2022-09-30 | -0.32 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.21 | 2023-08-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.